VIII.16 COMPRESSION PUMPS FOR TREATMENT OF LYMPHEDEMA AND VENOUS ULCERS (REQUIRES PREAUTHORIZATION)
COMPRESSION PUMPS FOR TREATMENT OF LYMPHEDEMA AND VENOUS ULCERS (REQUIRES PREAUTHORIZATION)
VIII.16
VIII.16 COMPRESSION PUMPS FOR TREATMENT OF LYMPHEDEMA AND VENOUS ULCERS (REQUIRES PREAUTHORIZATION)
Description
Compression pumps are proposed as a treatment for patients with lymphedema who have failed conservative measures. They are also proposed to supplement standard care for patients with venous ulcers. A variety of pumps are available; they can be single chamber (nonsegmented) or multichamber (segmented) and have varying designs and complexity. Non-pneumatic, programmable, wearable devices, are also available.
Dates
-
Original Effective
07-01-2026
-
Last Review
03-09-2026
-
Next Review
08-05-2026
Policy
I. Single-compartment or multichamber nonprogrammable pneumatic compression pumps applied to the limbs may be considered medically necessary for the treatment of lymphedema that has failed to respond to conservative measures, such as elevation of the limb and use of compression garments.
II. Single-compartment or multichamber programmable pneumatic compression pumps applied to the limbs may be considered medically necessary for the treatment of lymphedema when:
A. The individual is otherwise eligible for nonprogrammable pneumatic pumps; AND
B. There is documentation that the individual has unique characteristics (eg, significant scarring, recent surgery) that prevent satisfactory pneumatic compression with single-compartment or multichamber nonprogrammable compression pumps; OR
C. The individual has had an inadequate response to an initial course of treatment with a nonprogrammable pneumatic compression pump applied to the limbs (see Policy Guidelines).
III. Single-compartment or multichamber nonprogrammable pneumatic compression pumps applied to the chest or trunk in addition to the limbs may be considered medically necessary for the treatment of lymphedema that has failed to adequately respond to both conservative measures and nonprogrammable pneumatic compression to the limbs only.
IV. Single-compartment or multichamber programmable pneumatic compression pumps applied to the chest or trunk in addition to the limbs may be considered medically necessary for the treatment of lymphedema when:
A. The individual is otherwise eligible for nonprogrammable pneumatic pumps applied to the chest or trunk in addition to the limbs; AND
B. There is documentation that the individual has unique characteristics (eg, significant scarring, recent surgery) that prevent satisfactory pneumatic compression with single-compartment or multichamber nonprogrammable compression pumps; OR
C. The individual has had an inadequate response to an initial course of treatment with a nonprogrammable pneumatic compression pump applied to the chest or trunk in addition to the limbs (see Policy Guidelines).
V. Single-compartment or multichamber compression pumps are considered investigational in all situations other than those specified above, including when applied to the head or neck.
VI. Programmable, wearable non-pneumatic compression pumps (eg, Koya Dayspring) applied to the limbs may be considered medically necessary for the treatment of lymphedema when:
A. The individual is otherwise eligible for a programmable pneumatic compression pump; AND
B. There is documentation that the individual has lifestyle considerations or mobility requirements where treatment compliance with a traditional programmable, pneumatic compression system is expected to be insufficient.
VII. Programmable, wearable non-pneumatic compression pumps are considered investigational in all other situations not specified above.
VIII. The use of pneumatic or non-pneumatic compression pumps to treat venous ulcers is considered investigational.
Guidelines
Medically necessary positions for treatment of lymphedema at body sites other than the limbs are based on clinical input. Additional details from clinical input are detailed in the Appendix. Individuals who fail to respond to an initial trial of a nonprogrammable pump may benefit from programmable pumps with pulsatile features that can be tailored to address individual lymphatic flow dysfunction patterns. Clinical input supports the use of non-pneumatic compression pumps on the basis of the evidence and clinical experience, emphasizing the importance of compliance with treatment. Clinical input was mixed on the use of compression pumps for the treatment of head and neck lymphedema. Ongoing evidence generation in head and neck cancer populations is expected to elucidate clinical benefit.
Background
Lymphedema
Lymphedema is an accumulation of fluid due to disruption of lymphatic drainage. It is characterized by nonpitting swelling of an extremity or trunk, and is associated with wound healing impairment, recurrent skin infections, pain, and decreased quality of life. Lymphedema can be caused by congenital or inherited abnormalities in the lymphatic system (primary lymphedema) but is most often caused by acquired damage to the lymphatic system (secondary lymphedema). Breast cancer treatment (surgical removal of lymph nodes and radiotherapy) is one of the most common causes of secondary lymphedema. In a systematic review of 72 studies (N=29,612 women), DiSipio et al (2013) reported that nearly 20% of breast cancer survivors will develop arm lymphedema. The risk factors with robust evidence for the development of lymphedema included extensive surgical procedures (such as axillary lymph node dissection, a higher number of lymph nodes removed, and mastectomy) as well as being overweight or obese.
Diagnosis and Staging
A diagnosis of secondary lymphedema is based on history (e.g., cancer treatment, trauma) and physical examination (localized, progressive edema and asymmetric limb measurements) when other causes of edema can be excluded. Imaging, such as MRI, computed tomography, ultrasound, or lymphoscintigraphy, may be used to differentiate lymphedema from other causes of edema in diagnostically challenging cases.
Table 1 lists International Society of Lymphology guidance for staging lymphedema (2023) based on "softness" or "firmness" of the limb and the changes with an elevation of the limb.
Table 1. Recommendations for Staging Lymphedema
|
Stage |
Description |
|
Stage 0 (latent or subclinical) |
Swelling is not yet evident despite impaired lymph transport, subtle alterations in tissue fluid/composition, and changes in subjective symptoms. It can be transitory and may exist months or years before overt edema occurs (Stages 1-lll). |
|
Stage I (mild) |
Early accumulation of fluid relatively high in protein content (e.g., in comparison with "venous" edema) which subsides with limb elevation. Pitting may occur. An increase in various types of proliferating cells may also be seen. |
|
Stage II (moderate) |
Involves the permanent accumulation of pathologic solids such as fat and proteins and limb elevation alone rarely reduces tissue swelling, and pitting is manifest. Later in this stage, the limb may not pit as excess subcutaneous fat and fibrosis develop. |
|
Stage III (severe) |
Encompasses lymphostatic elephantiasis where pitting can be absent and trophic skin changes such as acanthosis, alterations in skin character and thickness, further deposition of fat and fibrosis, and warty overgrowths have developed. It should be noted that a limb may exhibit more than one stage, which may reflect alterations in different lymphatic territories. |
Management and Treatment
Lymphedema is treated using elevation, compression, and exercise. Conservative therapy may consist of several features depending on the severity of the lymphedema. Individuals are educated on the importance of self-care including hygiene practices to prevent infection, maintaining ideal body weight through diet and exercise, and limb elevation. Compression therapy consists of repeatedly applying padding and bandages or compression garments. Manual lymphatic drainage is a light pressure massage performed by trained physical therapists or by affected individuals designed to move fluid from obstructed areas into functioning lymph vessels and lymph nodes. Complete decongestive therapy is a multiphase treatment program involving all of the previously mentioned conservative treatment components at different intensities. Pneumatic compression pumps may also be considered as an adjunct to conservative therapy or as an alternative to self-manual lymphatic drainage in individuals who have difficulty performing self-manual lymphatic drainage. In individuals with more advanced lymphedema after fat deposition and tissue fibrosis has occurred, palliative surgery using reductive techniques such as liposuction may be performed.
Venous Ulcers
Venous ulcers, which occur most commonly on the medial distal leg, can develop in patients with chronic venous insufficiency when leg veins become blocked. Standard treatment for venous ulcers includes compression bandages or hosiery supplemented by conservative measures such as leg elevation.
Compression Pumps
Pneumatic compression pumps (PCPs) may be used in lymphedema or wound care clinics, purchased, or rented for home use; home use is addressed herein. PCPs consist of pneumatic cuffs connected to a pump. These pumps use compressed air to apply pressure to the affected limb. The intention is to force excess lymph fluid out of the limb and into central body compartments in which lymphatic drainage should be preserved. Many PCPs are available, with varying materials, designs, degrees of pressure, and complexity. There are 3 primary types of pumps. Single chamber nonprogrammable pumps are the simplest pumps, consisting of a single chamber that is inflated at 1 time to apply uniform pressure. Multichamber nonprogrammable pumps have multiple chambers ranging from 2 to 12 or more. The chambers are inflated sequentially and have a fixed pressure in each compartment. They can either have the same pressure in each compartment or a pressure gradient, but they do not include the ability to adjust the pressure manually in individual compartments. Single- or multi-chamber programmable pumps are similar to the pumps described above except that it is possible to adjust the pressure manually in the individual compartments and/or the length and frequency of the inflation cycles. In some situations, including patients with scarring, contractures, or highly sensitive skin, programmable pumps are generally considered the preferred option. PCPs are also proposed to supplement standard care for patients with venous ulcers. Recently, non-pneumatic, wearable compression pumps have become available. These garments can be programmed to provide graduated sequential compression therapy while providing patients with a functional range of motion and mobility.
Quick Code Search
Procedure
Diagnosis
Codes
Pneumatic compressor, non-segmental home model
Pneumatic compressor, segmental home model without calibrated gradient pressure
Pneumatic compressor, segmental home model with calibrated gradient pressure
Non-segmental pneumatic appliance for use with pneumatic compressor, half arm
Segmental pneumatic appliance for use with pneumatic compressor, trunk
Segmental pneumatic appliance for use with pneumatic compressor, chest
Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full arms and chest
Segmental pneumatic appliance for use with pneumatic compressor, integrated, head, neck and chest
Non-segmental pneumatic appliance for use with pneumatic compressor, full leg
Non-segmental pneumatic appliance for use with pneumatic compressor, full arm
Non-segmental pneumatic appliance for use with pneumatic compressor, half leg
Segmental pneumatic appliance for use with pneumatic compressor, full leg
Segmental pneumatic appliance for use with pneumatic compressor, full arm
Segmental pneumatic appliance for use with pneumatic compressor, half leg
Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full legs and trunk
Segmental gradient pressure pneumatic appliance, full leg
Segmental gradient pressure pneumatic appliance, full arm
Segmental gradient pressure pneumatic appliance, half leg
Pneumatic compression device, high pressure, rapid inflation/deflation cycle, for arterial insufficiency (unilateral or bilateral system)
Intermittent limb compression device (includes all accessories), not otherwise specified
Non-pneumatic sequential compression garment, full leg
Non-pneumatic sequential compression garment, half leg
Non-pneumatic compression controller with sequential calibrated gradient pressure
Non-pneumatic compression controller without calibrated gradient pressure
Non-pneumatic sequential compression garment, full arm
Non-pneumatic, non-sequential, peristaltic wave compression pump
References
|
2024
Yao M, Peng P, Ding X, et al. Comparison of Intermittent Pneumatic Compression Pump as Adjunct to Decongestive Lymphatic Therapy against Decongestive Therapy Alone for Upper Limb Lymphedema after Breast Cancer Surgery: A Systematic Review and Meta-Analysis. Breast Care (Basel). Jun 2024; 19(3): 155-164. PMID 38894955 |
|
2024
Hou S, Li Y, Lu W, et al. Efficacy of intermittent pneumatic compression on breast cancer-related upper limb lymphedema: a systematic review and meta-analysis in clinical studies. Gland Surg. Aug 31 2024; 13(8): 1358-1369. PMID 39282029 |
|
2023
International Society of Lymphology Executive Committee. The Diagnosis and Treatment of Peripheral Lymphedema: 2023 Consensus Document of the International Society of Lymphology. 2023; https://journals.librarypublishing.arizona.edu/lymph/article/id/6372/. |
|
2023
Cheng JT, Leite VF, Tennison JM, et al. Rehabilitation Interventions for Head and Neck Cancer-Associated Lymphedema: A Systematic Review. JAMA Otolaryngol Head Neck Surg. Aug 01 2023; 149(8): 743-753. PMID 37382963 |
|
2013
DiSipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. May 2013; 14(6): 500-15. PMID 23540561 |
|
2022
Rockson SG, Whitworth PW, Cooper A, et al. Safety and effectiveness of a novel nonpneumatic active compression device for treating breast cancer-related lymphedema: A multicenter randomized, crossover trial (NILE). J Vasc Surg Venous Lymphat Disord. Nov 2022; 10(6): 1359-1366.e1. PMID 35952956 |